EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

USP53 Exerts Tumor-Promoting Effects in Triple-Negative Breast Cancer by Deubiquitinating CRKL

Yi Liu iD, Wei Tang, Feng Yao iD

Cancers · 18.10.2023 · 15 (20) · 5033

DOI: 10.3390/cancers15205033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 18.10.2023. Verfasst von Yi Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Feng Yao, National Major Scientific Instruments and Equipment Development Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) ranks in the top five malignant tumors in terms of morbidity and mortality rates. Among BC subtypes, TNBC has a high recurrence rate and metastasis rate and the worst prognosis. However, the exact mechanism by which TNBC develops is unclear. Here, we show that the deubiquitinase USP53 contributes to tumor growth and metastasis in TNBC. USP53 is overexpressed in TNBC, and this phenotype is linked to a poor prognosis. Functionally, USP53 promotes TNBC cell proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT). More importantly, USP53 decreases the chemosensitivity of BC cells by enhancing v-crk sarcoma virus CT10 oncogene homologue (avian)-like (CRKL) expression. Mechanistically, USP53 directly binds CRKL to stabilize and deubiquitinate it, thereby preventing CRKL degradation. Overall, we discovered that USP53 deubiquitinates CRKL, encourages tumor development and metastasis, and reduces chemosensitivity in TNBC. These findings imply that USP53 might represent a new therapeutic target for the treatment of TNBC.

Schlagwörter

Stichwörter der Autor:innen

CRKLUSP53deubiquitinaseepithelial–mesenchymal transitiontriple-negative breast cancer

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Department of Pediartrics, Renmin Hospital of Wuhan University, Wuhan 430060, China.

ORCID-Profile: Yi Liu, Feng Yao

Förderung

  • Feng Yao
  • National Major Scientific Instruments and Equipment Development Projects

Zitieren

APA

Liu, Y., Tang, W., & Yao, F. (2023). USP53 Exerts Tumor-Promoting Effects in Triple-Negative Breast Cancer by Deubiquitinating CRKL. Cancers, 15(20), 5033. https://doi.org/10.3390/cancers15205033

Vancouver

Liu Y, Tang W, Yao F. USP53 Exerts Tumor-Promoting Effects in Triple-Negative Breast Cancer by Deubiquitinating CRKL. Cancers. 2023;15(20):5033. doi:10.3390/cancers15205033

BibTeX
@article{Liu2023,
  author = {Liu, Yi and Tang, Wei and Yao, Feng},
  title = {USP53 Exerts Tumor-Promoting Effects in Triple-Negative Breast Cancer by Deubiquitinating CRKL},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {20},
  pages = {5033},
  doi = {10.3390/cancers15205033}
}
Kostenlos starten →